Dynavax to Present at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference

Rhea-AI Summary

Dynavax to present at H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference

Positive

• Dynavax Technologies Corporation will present at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference on October 25 at 1:00 p.m. ET

Negative

• None.

EMERYVILLE, Calif., Oct. 19, 2023 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference on Wednesday, October 25 at 1:00 p.m. ET.

The presentation will be webcast and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at https://investors.dynavax.com/events-presentations.

About Dynavax

Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B^® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S., the European Union and Great Britain for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older, and CpG 1018^® adjuvant, currently used in multiple adjuvanted COVID-19 vaccines. Dynavax is advancing CpG 1018 adjuvant as a premier vaccine adjuvant with adjuvanted vaccine clinical programs for shingles and Tdap, and through global collaborations, currently focused on adjuvanted vaccines for COVID-19, plague, seasonal influenza and universal influenza. For more information about our marketed products and development pipeline, visit www.dynavax.com and follow Dynavax on LinkedIn and Twitter.

For Investors/Media:
Paul Cox
pcox@dynavax.com
510-665-0499

Nicole Arndt
narndt@dynavax.com
510-665-7264

View original content to download multimedia:https://www.prnewswire.com/news-releases/dynavax-to-present-at-the-hc-wainwright-4th-annual-hepatitis-b-virus-virtual-conference-301962390.html

SOURCE Dynavax Technologies

FAQ

When is Dynavax presenting at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference?

Dynavax will present on October 25 at 1:00 p.m. ET.

Where can I access the webcast of the presentation?

The webcast can be accessed through the 'Events & Presentations' page on the 'Investors' section of Dynavax's website at https://investors.dynavax.com/events-presentations.